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ABSTRACT
De novo biosynthesis of pyrimidine nucleotides
provides essential precursors for DNA synthesis
and cell proliferation. The first three steps of de
novo pyrimidine biosynthesis are catalyzed by a
multifunctional enzyme known as CAD (carbamoyl
phosphate synthetase-aspartate carbamoyltransfer-
ase-dihydroorotase). In this work, a decrease in
CAD expression is detected in numerous cell lines
and primary culture human stromal cells incubated
under hypoxia or desferrioxamine (DFO)-induced
HIF-1a accumulation. A putative hypoxia response
element (HRE) binding matrix is identified by analyz-
ing human cad-gene promoter using a bioinformatic
approach.Promoteractivityassays,usingconstructs
harboringthecadpromoter( 710/1122)andthe 67/
HRE fragment (25-bases), respectively, demonstrate
the suppression of reporter-gene expression under
hypoxia. Suppression of cad-promoter activity is
substantiated by forced expression of wild-type
HIF-1a but abolished by overexpression of
dominant-negative HIF-1a. A chromatin immuno-
precipitation assay provides further evidence that
HIF-1a binds to the cad promoter in vivo. These
data demonstrate that the cad-gene expression is
repressed by HIF-1a, which represents a functional
link between hypoxia and cell-cycle arrest.
INTRODUCTION
Hypoxia is an environmental stress that trigger with important
implications in the pathogenesis of major causes of mortality
including cancer, cerebral and myocardial ischemia, pre-
eclampsia, and chronic heart and lung diseases. In recent
years, many studies have shown that hypoxia can inhibit or
even completely abolish cell proliferation (1–8), which is
directly involved in the chemoresistance and radioresistance
of hypoxic tumors because, chemo- and radiotherapy are
efﬁcient only against rapidly dividing cells. Thus, understand-
ing the mechanisms responsible for cell-cycle arrest under
hypoxic stress might help to circumvent these two forms of
resistance.
The expression of hypoxia-responsive genes is regulated
primarily by the transcription factor hypoxia-inducible factor
(HIF). HIF consists of an inducible a subunit and a con-
stitutively expressed b subunit. Three variants of HIF-a
(HIF-1a,- 2 a and -3a) have been identiﬁed (9); all of them
dimerize with HIF-1b (also known as aryl hydrocarbon nuc-
lear translocator, ARNT) to form a heterodimeric functional
unit. HIF-1a is expressed in most, if not all, human tissues
(10), while HIF-2a and HIF-3a are expressed in more restric-
ted tissues and developing stages such as the fetal lung and
vascular endothelium (11–13). In addition, HIF-1a appears to
play a general role in the transcriptional regulation of all cells
in response to hypoxia, whereas HIF-2a and HIF-3a play
more limited or specialized roles in oxygen homeostasis.
Recent studies (1–3) have demonstrated that hypoxia may
lead to apoptosis of some transformed cell lines, while non-
transformed cells are viable under hypoxic condition but are
arrested in the G1/S-phase. Upregulation of HIF-1a caused by
hypoxia inhibits cell-cycle progression in most normal and
cancer cells (4–8). However, the mechanism of HIF-1a-
induced cell-cycle arrest has not been uniformly resolved.
Hypoxia-induced cell-cycle arrest causes the elevation of
checkpoint proteins such as p53, p21 and p27 in direct relation
to the expression level of HIF-1a (3,14). In contrast, a recent
study demonstrated that embryonic ﬁbroblast cells without
p21 and p27 are capable of hypoxia-induced S-phase arrest,
but that re-entry into the cell-cycle after reoxygenation is
delayed (8).Most importantly,direct evidence ofthetranscrip-
tional regulation of these checkpoint proteins by HIF-1a
has never been demonstrated. Therefore, it is hypothesized
that the elevation of checkpoint proteins under hypoxia is the
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shortage is the primary cause of the arrest (1).
The de novo biosynthesis of pyrimidine nucleotides
provides essential precursors for DNA synthesis and cell pro-
liferation. Pyrimidine biosynthesis is not only a prerequisite
for cells to enter the S-phase, but also it plays a dominant role
in regulating cell-cycle progression due to the increased
demand for nucleotides for DNA synthesis in rapidly pro-
liferating cells. The ﬁrst three steps of de novo pyrimidine
biosynthesis are catalyzed by a multifunctional cytoplasmic
enzyme known as CAD (carbamoyl phosphate synthetase-
aspartate carbamoyltransferase-dihydroorotase) (15,16).
Over the past decade, extensive advances have been made
in elucidating the mechanisms of the de novo biosynthesis
of pyrimidine nucleotide in mammalian cells. The cloning
of the human cad gene and the characterization of its prop-
erties provided the major breakthrough for our understanding
of the principles and regulation of pyrimidine biosynthesis in
cancerous and non-cancerous cells. It is clear that CAD cata-
lyzes the rate-limiting step in the de novo pyrimidine synthetic
pathway (17), and that it therefore controls the rate of DNA
synthesis. Transcriptional upregulation of cad promoter by
growth factors and steroids that ultimately leads to an increase
in cell proliferation has been reported. Mitogen-activated pro-
tein kinase (MAPK) and the transcription factor c-Myc medi-
ates the growth-factor-induced CAD overexpression, and
estrogen upregulates cad-promoter activity via the binding
of ER and SP1 to the GC box of cad promoter (18,19).
The biosynthesis of pyrimidine nucleotides is inhibited by
hypoxia, which ultimately leads to reduced DNA synthesis,
hence inhibiting cell-cycle progression (7,20,21). Addition of
exogenous pyrimidine nucleotides causes re-entry into the
S-phase and initiates replication in hypoxic cells (7). Because
CAD controls the ﬁrst three enzymatic activities of pyrimidine
nucleotide biosynthesis, reducing pyrimidine nucleotide
production in hypoxic cells may be mediated by inhibiting
CAD expression. Furthermore, HIF-1a is the master transcrip-
tion factor in regulating hypoxia-responsive gene expression;
thus, we hypothesize that HIF-1a may directly inhibit cad
under hypoxia condition. This study aims to investigate regu-
lation of CAD by HIF-1a using both in vitro and in vivo
approaches.
MATERIALS AND METHODS
Cell culture and hypoxia treatment
Cell lines were maintained in speciﬁc culture media recom-
mended by the American Type Culture Collection (ATCC),
and were supplemented with 10% fetal bovine serum (FBS).
The human endometrial stromal cells were puriﬁed and
cultured in DMEM/F12 medium with 10% FBS, as previously
described (22,23). Between 18–24 h before undergoing
hypoxia, cells were plated at a density of 5 · 10
5 cells per
30 mm glass dish. The medium was changed  1 h before
treatment to assure an adequate amount of nutrient and
growth factor. Hypoxic treatment was carried out in an incub-
ator with 1% O2,5 %C O 2 and 94% N2, or with desferriox-
amine (DFO), as indicated. Oxygen concentration was
monitored using an oxygen electrode (OS1000; Oxygen
Sensors, Inc, Frazer, PA).
RNA isolation and real-time RT–PCR
Total RNA was isolated from cells using a kit (RNeasy Mini
Kit; Qiagen, Valencia, CA) according to the manufacturer’s
instructions. RNA concentrations were determined using
UV-absorption at 260 nm, and then subjected to reverse-
transcription at 42 C for 60 min, denaturing, and PCR
ampliﬁcation using a thermal cycler (ABI 7900; Applied
Biosystems, Foster City, CA). To determine the amounts of
CAD transcript, real-time RT–PCR was conducted. In this
reaction, SYBR Green I was added to the PCR master mix
and served as a ﬂuorescence source for laser detection. The
cycling conditions were 95 C for 10 min, 40 cycles at 95 C
for 15 s and 60 C for 1 min. The reaction data were expres-
sed as copies/mg of RNA, after converting the number of
cycle thresholds (Ct)-the PCR cycle number at which the
ﬂuorescent signal in each reaction reaches a preset threshold
above background-to absolute value according to the
standard curve. A dissociation curve was created using the
built-in melting-curve program to conﬁrm the presence of
a single PCR product. 18S rRNA was used as an internal
control, for which the primer sequences were previously
reported (24).
Plasmids, transfection, and promoter-activity assays
Human HIF-1a CEP4/HIF-1a (ATCC Cat no.: MBA-2) and
dominant-negative form HIF-a pCEP4/HIF-1aDN (ATCC
Cat no.: MBA-7) plasmids were purchased from the American
Type Culture Collection (ATCC, The Johns Hopkins Univer-
sity, Baltimore, MD). Human cad promoter ( 710/+122) was
cloned to pGL3 basic vector (Promega Corp., Madison, WI)
using PCR with a pair of primers: (forward: 50-ctagctagcta-
gAAAGGAGAGCCACAAGACCA-30; reverse: 50-ccgctcgag-
cggGGAAGGACTGCAAACTCCAC-30), which contained
NheI and XhoI restriction sites (underlined), respectively.
Alternatively, two 25-base oligonucleotides: (forward: 50-ctag-
CCGCCCCTTACGTGCCCGGCCCCGC-30, reverse: 50-tcga-
GCGGGGCCGGGCACGTAAGGGGCGG-30) corresponding
to human cad HRE matrix ( 76/ 52) were synthesized and
cloned into SV40-driven pGL3 plasmid after annealing.
Mutation of the putative HRE sequence was achieved by
replacing the bases ACGTG with ATTAG.
Cells were placed on 24-well plates for luciferase assays.
Commercial plasmids containing a CMV-driven b-galactosi-
dase reporter system (Promega, Madison, WI) were transfec-
ted into the cells using Lipofectamine 2000 (Invitrogen Life
Technologies, Carlsbad, CA). After transfection, the cells
were allowed to rise and incubated in serum-free DMEM/
F12 medium for 6 h. The medium was then changed, and
cells were subjected to hypoxic treatment for the indicated
time. Luciferase assays were done using a kit (Dual Luciferase
Reporter Assay System, Promega) according to the manufac-
turer’s instructions. Brieﬂy, 100 ml of luciferase substrates
were added to20mloflysate,andluciferaseactivitywasmeas-
ured using a 20/20 luminometer (Turner Designs, Sunnyvale,
CA). Each luciferase assay experiment was performed in
duplicate and repeated as indicated in the ﬁgure legends.
SiRNA
Short interference RNA (siRNA) against human HIF-1a
was synthesized by Qiagen. Sequences for siHIF-1a
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r(UCAAGUUGCUGGUCAUCAUCAG)d(TT)-30. For negat-
ive control, two ribonucleotides with scrambled sequences
50-r(AGUUCAACGACCAGUAGUC)d(TT)-30 and 50-r(GA-
CUACUGGUCGUUGAACU)d(TT)-30 werealsosynthesized.
The ribonucleotides were dissolved in the siRNA suspension
buffer (Qiagen), heated to 90 C for 1 min, and incubated at
37 C for 60 min. The annealed siRNA (5 mg) was used to
transfect cells according to manufacturer’s instruction (Qia-
gen). After transfection, cells were incubated with or without
10 mM DFO for 8 h and subjected to RNA isolation and real-
time RT–PCR quantiﬁcation as described above.
Chromatin immunoprecipitation
(ChIP)-PCR assay
The protocol used was as described before (24) with modi-
ﬁcations. In brief, proteins (HIF-1a) and DNA in normoxia,
hypoxia, or DFO-treated cells (1 · 10
6 cells) were
cross-linked by incubation for 10 min at 37 C with a ﬁnal
concentration of 1% formaldehyde. After aspiration of the
formaldehyde,the cells were washed twicewithice-cold phos-
phate-buffered saline (PBS) containing protease inhibitors
(1 mM phenylmethylsulfonyl ﬂuoride and 1 mg/ml each of
aprotinin, and pepstatin A) and scraped into a conical tube.
Thelysatewasthencentrifugedinadesktopcentrifuge(Model
5415R, Eppendorf, Hamburg, Germany) for 5 min at 500 g at
4 C, resuspended in 400 ml of lysis buffer [1% SDS, 10 mM
EDTA, and 50 mM Tris–HCl (pH 8.1)], and placed on ice for
10 min. Genomic DNA was sheared to lengths of 0.5–1 kb by
sonicating the cell lysate, then debris was removed by centri-
fugation, and the supernatant diluted with 1 ml of ChIP dilu-
tion buffer [0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA,
16.7 mM Tris–HCl, 16.7 mM NaCl and proteinase inhibitors
(pH 8.0)]. Two percent of the diluted lysate was kept for input
control. The chromatin solution was pre-cleared with mixtures
containingBSA,salmonspermDNAandproteinASepharose.
Anti-HIF-1a antibody or rabbit IgG (for negative control) was
added to the supernatant fraction and the mixture was incub-
ated overnight at 4 C with rotation. Then, 60 ml of salmon
sperm DNA/Protein A agarose slurry was added to the mixture
and incubated for 1 h at 4 C with rotation. The protein A
agarose/antibody/HIF-1a complex was pelleted by gentle
centrifugation (400 g at 4 C for 1 min) in a desktop centrifuge
(Eppendorf, Model 5415R). The pellet was washed sequent-
ially (5 min per wash) on a rotating platform with 1 ml each of
low salt washing buffer [0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris–HCl and 150 mM NaCl (pH 8.0)], high
salt washing buffer [0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris–HCl and 500 mM NaCl (pH 8.0)],
LiCl washing buffer [0.25 M LiCl, 1% NP-40, 1% sodium
deoxycholate, 1 mM EDTA and 10 mM Tris–HCl (pH 8.0)]
and 1· TE buffer [10 mM Tris–HCl and 1 mM EDTA (pH
8.0)]. After the ﬁnal wash, the pellet was eluted by resuspen-
sion in freshly made elution buffer (1% SDS and 50 mM
NaHCO3), followed by centrifugation. Twenty microliters
of 5 M NaCl was added to the supernatant and the mixture
incubated for 4 h at 65 C to reverse the protein–DNA cross-
linking, and then the DNA was ampliﬁed using PCR. The
cycling conditions were 95 C for 10 min, followed by 30
cycles of 95 C for 30 s, 60 C for 30 s and 72 C for 30 s.
Statistical analysis
The data were expressed as mean ± standard error of the mean
(SEM). Differences between groups were analyzed using one-
way ANOVA in commercial statistical software (GraphPad
Prism 4.02; GraphPad Software, San Diego, CA). Tukey’s
procedure was used to test differences between groups
found signiﬁcant using the F-test. Student’s t-test was used to
compare differences between normoxic and hypoxic groups.
Statistical signiﬁcance was set at P < 0.05.
RESULTS
Expression of CAD is cell-cycle-dependent
The expression of CAD provides a functional enzyme for the
biosynthesis of pyrimidine nucleotides, the critical constituent
for DNA synthesis and cell-cycle progression. To determine
the expression levels of CAD in different cell types, mRNA
encoding for CAD was quantiﬁed using real-time RT–PCR.
The expression level of CAD was associated with the prolif-
eration speed of each cancer cell line. Expression levels for the
colo320DM and IMR32 lines (doubling time: < 24 h) were
signiﬁcantly higher than for the primary cultured endometrial
stromal cells (doubling time: > 48 h) (Figure 1). In addition,
expression of CAD was cell-cycle-dependent. In colo320DM
cells, CAD transcripts increased 4 h after serum stimulation,
reached peak value at 8 h, returned to basal level at 16 h, and
rose again at 24 h (Figure 1). Levels of CAD mRNA in IMR32
did not increase until 8 h after serum stimulation, maintained
at the high value at 16 h, and returned to basal level at 24
h (Figure 1). In stromal cells, which showed no measurable
proliferation within 24 h after serum stimulation, the CAD
level predictably did not change (Figure 1).
Hypoxia inhibits the expression of CAD mRNA
In order to investigate whether the expression of CAD is
regulated by hypoxia, we compared the mRNA levels of
CAD in cells cultured under normoxic (21% O2) or hypoxic
(1% O2) conditions. In colo320DM cells exposed to hypoxia,
Figure 1. Expression of CAD mRNA in different cell types after serum sti-
mulation.Cellswereserum-starvedfor24handthenincubatedinfreshmedium
containing 10% serum. Total RNA was isolated from cells at time points
indicated and subjected to RT–PCR amplification. Concentrations of CAD
transcripts were determined by real-time RT–PCR. Different letters indicate
significant difference within each cell type (P < 0.05). Colo320DM: colon
cancer cell line, IMR32: neuroblastoma cell line, stroma: primary cultured
human uterine endometrial stromal cells.
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points (Figure 2A). To test whether hypoxia-induced sup-
pression of CAD mRNA expression is a common effect,
three other cell lines (A293T, IMR32 and HeLa) and
human endometrial stromal cells were exposed to normoxia
or hypoxia for 16 h, and their levels of mRNA were analyzed.
Hypoxia treatment signiﬁcantly inhibited CAD mRNA
expression in all cells tested (Figure 2B), which indicated
that it is a common phenomenon. It has been reported that
hypoxia may induce apoptosis in p53
+/+ cells (2). To test
whether the decrease in CAD mRNA expression under
hypoxia condition is due to hypoxia-induced cell death, cell
numbers were calculated 16 h after hypoxia treatment.
No signiﬁcant decreases in cell numbers were observed in
any of the cell lines used (data not shown). In addition, expres-
sion of another hypoxia-regulated gene, VEGF, was exam-
ined using simple RT–PCR as an internal control because
hypoxia induces VEGF expression in many cell types
and solid tumors. In fact, VEGF expression increased in
cells exposed to hypoxia for 24 h even though CAD
mRNA expression decreased (Figure 2C). Together, these
data demonstrate that hypoxia speciﬁcally suppressed CAD
mRNA expression.
Suppression of CAD expression under chemical hypoxia
Hypoxia-regulated gene expression is either HIF-1-dependent
or HIF-1-independent. To determine whether suppression of
CAD expression under hypoxia is mediated by HIF-1, cells
were treated with DFO, an iron chelator that causes HIF-1a to
accumulate. DFO treatment caused a dose-dependent increase
in nuclear HIF-1a (Figure 3A). A time-course experiment
demonstrated that accumulation of HIF-1a had discernibly
accumulated in the nucleus 4 h after treatment in colo320DM
cells, peaked at 8 h, and remained for at least 24 h (Figure 3A,
D4, D8, D16, D24). Similarly, the expression of CAD was
time-dependently suppressed after treatment with DFO under
normoxic conditions (Figure 3B). Although the suppression
pattern was somewhat different in different cell types, it seems
clear that DFO reduced CAD expression in all four cell lines
(colo320DM, HeLa, A293T and IMR32) as well as in the
primary cultured stromal cells (Figure 3B). Again, the cell
Figure 2. HypoxiasuppressesCADmRNAexpression.(A)Colo320DMcellswereserum-starvedfor24hfollowedbyadditionoffreshmediumsupplementedwith
10%FBS.Cellswerethenculturedinhypoxicchamber(hypoxia,1%O2)orregularincubator(normoxia,21%O2)for4,8,16and24h,respectively.TotalRNAwas
isolated and levels of CAD transcripts were determined by real-time RT–PCR as described in experimental procedures. The data show means and standard errors
obtained from three independent experiments performed in duplicated. Asterisk indicates significant difference (P < 0.05) compared to same time point normoxia
groupby unpairedt-test.(B) Serum-starvedcellswere culturedin freshmediumsupplementedwith10%FBSundernormoxiaandhypoxiaconditions,respectively
for16handexpressionofCADmRNAwasquantified.Datashowmeanvaluesofhypoxiatonormoxiaratioofthreeindependentexperiments.Threehumancelllines
(293T,HeLaandIMR32)andoneprimaryculturehumanuterineendometrialstromalcell(stroma)wereused.(C)Serum-starvedColo320DMcellswereculturedin
freshmediumsupplementedwith10%FBSundernormoxiaandhypoxiaconditions,respectivelyfor16handexpressionofCADandVEGFmRNAwasdetermined
by simple RT–PCR.
Figure 3. Hypoxia-suppressed CAD expression can be mimicked by DFO treatment. (A) Serum-starved colo320DM cells were cultured in fresh medium
containing 10% FBS in the presence or absence of different concentrations of DFO and levels of nuclear HIF-1a and HIF-1b were determined (upper
panel). Lower panel shows that nuclear HIF-1a in cells treated with 10 mM DFO for different length of time as indicated. This experiment was repeated
three times with similar result. (B) Serum-starved cells were cultured in fresh medium supplemented with 10% FBS in the presence or absence of 10 mM
DFOfor0,4,8,16or24h.ExpressionofCADtranscriptswerequantifiedbyreal-timeRT–PCR.Datarepresentmeanvalueofratiotountreatedcontrolatthesame
time point (n ¼ 3–4 for each cell types quantified in duplicate). (C) A representative gel picture shows RT–PCR products of CAD and VEGF after DFO treatment
for 24 h.
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lated the expression of VEGF mRNA (Figure 3C and data not
shown), which indicated DFO did not induce apoptosis in
these cells within 24 h.
Identification of functional HRE in human
cad-gene promoter
Based on these data, we investigated whether repression of
CAD by hypoxia could be regulated by HIF-1 at the transcrip-
tional level. The sequence of cad promoter, available in the
human genome database (Ensembl), was retrieved and ana-
lyzed for putative HRE sites using a hidden Markov model
(HMM). An HRE matrix-containing the core sequence (50-
RCGTG-30) was identiﬁed at the  67/ 54 of cad promoter
(Figure 4A). To test whether this HRE matrix is functional, the
50-ﬂankingsequence ofhumancad( 710/+122)wasclonedto
a pGL3 basic luciferase reporter plasmid. Exposing cells tran-
siently transfected with plasmid containing cad promoter to
1% oxygen signiﬁcantly reduced reporter-gene expression
(Figure 4B); the reduction was inversely correlated with the
elevationofHIF-1ainthenucleus (Figure4C).This resultwas
indisputably replicated in primary culture cells and three other
cell lines (Figure 4D and data not shown) indicating, again,
that it is a common event. Because DFO treatment also
reduced CAD expression, we tested whether DFO suppressed
cad-promoter activity. As expected, treatment with DFO
dose-dependently reduced reporter-gene expression in cells
transfected with plasmids containing cad promoter
(Figure 4E).
One study reported that the core HRE (50-RCGTG-30)i s
necessary but not sufﬁcient for HIF-mediated promoter activ-
ity(25). To test whether this HRE matrix is indeed a functional
HIF-1-regulated region, two 25 bp oligonucleotides corres-
ponding to the  76/ 52 segment of the human cad-gene
promoter region were synthesized and cloned to an SV40
promoter containing pGL3 plasmid (Figure 5A). Insertion
of the HRE matrix into pGL3-SV40 plasmid caused a 2-fold
increase in promoter activity when cells were cultured in nor-
moxic conditions (Figure 5B). When exposed to hypoxia,
reporter-gene expression decreased in cells transfected with
this HRE-containing plasmid (Figure 5B).
To examine whether the effect of cad HRE was due to
alteration of intact SV40 promoter, a 47 bp VEGF HRE
(26) was cloned to the same position in the pGL3-SV40 plas-
mid, and luciferase activity was measured. The VEGF HRE
did not alter promoter activity under normoxic conditions but
it did induce reporter-gene expression under hypoxic condi-
tions (Figure 5B). Similarly, cells transfected with plasmid
containing the HRE matrix of the cad gene showed reduced
promoter activity after being treated with 10 mM DFO
(Figure 5C). In contrast, DFO treatment did not inhibit
Figure 4. HIF-1a suppressed promoter activity of human cad gene. (A) Schematic drawing of human cad-gene promoter shows location and sequences of
bioinformatic predicted HRE matrix with core HRE in underlined bold face. Arrows indicate primers for chromatin immunoprecipitation-PCR assay.
(B) Colo320DM cells was transfected with pGLbasic plasmid or pGL basic plasmid with human cad promoter (designated as pCAD) and subjected to normoxia
(21%O2)orhypoxiatreatment(1%O2)asdescribedinexperimentalprocedures.Datashowmeansandstandarderrorsofthreeindependentexperimentsperformed
in duplicate. Asterisk indicates significant difference compared to normoxia group a P < 0.05. (C) A representative western blot result shows nuclear HIF-1a and
lamininincellsculturedundernormoxia(21%O2),8%O2,or1%O 2for16h.Thisexperimentwasrepeatedthreetimeswithsimilarresult.(D)Primaryculturehuman
endometrialstromalcellsweretreatedasdescribedinBandhumancad-promoteractivitywasdetermined.Datashowmeansandstandarderrorsoffourindependent
experiments using different batches of cells performed in duplicate. Asterisk indicates significant difference compared to normoxia group at P < 0.05.
(E) Transfected colo320DMcells were treated with different concentrations of DFO for 16 h and promoter activity was determined. Data show meansand standard
errors of three independent experiments performed in duplicate. Different letters indicate significant difference (P < 0.05).
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containing mutated HRE matrix (Figure 5C). Forced expres-
sion of wild-type HIF-1a signiﬁcantly inhibited cad-promoter
activity and this effect was further substantiated by
DFO treatment (Figure 5D). Inversely, transfection with
dominant-negativeHIF-1aplasmiddose-dependentlyrestored
cad-promoteractivityinhibited byDFO treatment(Figure5E).
DFO treatment induced reporter-gene activity in cells co-
transfected with pVEGF-SV40 and control plasmid, but this
effect was abolished by overexpression of dominant-negative
HIF-1a (Figure 5F). Taken together, these data provide further
evidence that supports the functional role of HIF-1a in tran-
scriptional repression of cad-gene activity in a gene-speciﬁc
manner.
Suppression of cad-gene expression under hypoxia is
HIF-1a dependent
To determine the crucial role of HIF-1a in hypoxia-
mediated down-regulation of cad-gene expression, speciﬁc
siRNA against HIF-1a was used to knock down HIF-1a
and expression of CAD transcripts were determined under
chemical hypoxia. Transfection of HIF-1a siRNA (siHIF)
signiﬁcantly inhibited DFO-induced HIF-1a protein accumu-
lation while transfection of siRNA with scrambled sequence
(sr-HIF) did not have similar effect (Figure 6A). Levels of
endogenous CAD transcripts were signiﬁcantly decreased in
mock transfected cells treated with DFO (Figure 6B). The
suppressive effect was reversed by prior transfection with
siHIF-1a but not sr-HIF (Figure 6B) indicating suppression
of CAD expression by DFO is HIF-1a dependent.
Binding of HIF-1a to the cad-promoter HRE
So far, we have identiﬁed that HIF-1a transcriptionally inhib-
its cad-gene expression. To demonstrate that HIF-1a physic-
ally binds to the cad-promoter HRE matrix and regulates
cad-gene activity,colo320DMcells were exposed tonormoxia
or hypoxia for different periods of time, and the binding of
HIF-1a to cad promoter was analyzed using a ChIP assay.
HIF-1a bound signiﬁcantly to the cad promoter by 16 h
after hypoxia treatment (Figure 7A). In contrast, non-
speciﬁc binding was unaffected by hypoxia treatment, as
demonstrated by results using rabbit IgG as the primary anti-
body for immunoprecipitation (Figure 7A). Similar results
were obtained when cells were treated with 1 mM DFO
(Figure 7B). The binding of HIF-1a to cad promoter was
signiﬁcantly increased by DFO treatment by as early as 4
h, and it remained so for up to 24 h (Figure 7B). In IMR32
neuroblastoma cells, basal binding of HIF-1a to cad promoter
under normoxia was greater, but DFO treatment also increased
the binding (Figure 7B).
Figure 5. Effect of dominant-negative form HIF-1a on hypoxia-regulated cad-promoter activity. (A) Schematic drawing of reporter constructs depicts that the
25-base HRE matrix of human cad gene was inserted between NheI and XhoI sites of pGL-SV40 vector. (B) Colo320DM cells were transfected with pGL-SV40
vectororHREmatrix-containingpCAD-SV40plasmidandsubjectedtonormoxiaorhypoxiatreatmentasdescribedinexperimentalprocedure.Aspositivecontrol,a
47-baseVEGFHREwasalsoligatedtothesamepGL-SV40vector(termedpVEGF-SV40)andwasusedtoperformidenticalexperimentasdescribedaboveside-by-
side.Datashowmeansandstandarderrorsofthreeindependentexperimentsperformedinduplicate.Asteriskindicatessignificantdifferencefromnormoxiagroupby
unpaired t-test at P < 0.05. (C) Cells were transfected with plasmids containing wild-type (pCAD-SV40) or mutated (pMuCAD-SV40) HRE as described.
Transfected cells were then treated with 10 mM DFO for 16 h and luciferase activity was measured. Data show means and standard errors of three independent
experimentsperformedinduplicate.Asteriskindicatessignificantdifferencefromuntreatedgroupbyunpairedt-testatP < 0.05.(D)Cellswereco-transfectedwith
pCADandHIF-1aorcontrolvectorandthentreatedwithorwithoutDFO(10mM)for16h.Datashowmeansandstandarderrorsofthreeindependentexperiments
performed in duplicate. Different letters indicate significant difference (P < 0.05). (E and F) Cells were co-transfected with pCAD-SV40 (E) or pVEGF-SV40
(F)anddifferentamountsofdominant-negativeHIF-1avector(DN-HIF)orcontrolvectorasindicated.Transfectedcellswerethentreatedwith10mMDFOfor16h
and luciferase activity was measured. Data show means and standard errors of three independent experiments performed in duplicate. Different letters indicate
significant difference (P < 0.05).
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Hypoxic stress inhibits de novo biosynthesis of pyrimidine
nucleotides, thus leading to cell-cycle arrest due to an insuf-
ﬁcient supply of building materials for DNA synthesis (7).
Nevertheless, how hypoxia causes reduction in pyrimidine
biosynthesis remains enigmatic. The present study provides
evidence demonstrating that HIF-1a transcriptionally inhibits
the cad gene, which encodes a multifunctional enzyme that
controls the rate-limiting step of pyrimidine biosynthesis
(15,16). This conclusion is based on results obtained in experi-
ments in which CAD expression declined in response to an
increase in cellular levels of HIF-1a. A functional HRE was
identiﬁed in human cad promoter, which was bound by
HIF-1a as demonstrated by the ChIP assay. The use of
dominant-negative form HIF-1a totally abolished the hypoxic
effect provided further evidence to show the pivotal role of
HIF-1a in suppressing cad-promoter activity. Furthermore,
increasing HIF-1a levels in colo320DM, HeLa, A293T,
IMR32 and primary endometrial stromal cells signiﬁcantly
inhibited cad expression, which unequivocally proved that
repression of cad-promoter activity by HIF-1a is common
in hypoxic cells. Taken together, our current data provide
evidence to support that hypoxia-induced cell-cycle arrest
might be the result of the inhibition of CAD expression by
HIF-1a.
DNA synthesis diminishes when oxygen is reduced from
cell culture (27), which ultimately leads to cell-cycle arrest at
the G1/S-phase. Previous studies focused on two oxygen-
dependent enzymes, ribonucleotide reductase and dihydrooro-
tate dehydrogenase. They concluded by hypothesizing that
inactivation of these enzymes under hypoxia is the primary
cause of a shortage of deoxynucleotide precursors for DNA
replication and a consequent arrest of cell-cycle progression
(28,29). However, these two enzymes work downstream of
CAD, and other studies (15,16) suggest that the rate-limiting
reaction of the entire pyrimidine synthesis is actually con-
trolled at the step of converting glutamine to dihydroorotate,
which involves three enzymatic activities possessed by CAD.
In agreement with these reports, our results demonstrated that
the expression of CAD is highly associated with the cell-cycle
progression and the expression level of CAD truly reﬂects the
proliferation rateofcells.Thehighest level ofCAD expression
in colo320DM cells occurred between 4 and 8 h after serum
stimulation, which demonstrates CAD’s functional role of
providing nucleotides for DNA replication. Furthermore, we
found that oxygen deprivation or increased cellular HIF-1a
levels induced by DFO treatment signiﬁcantly reduced the
levels of CAD transcripts in colo320DM, HeLa, A293T,
IMR32 and human endometrial stromal cells. These results
not only demonstrate hypoxia-down-regulated CAD expres-
sion is a common phenomenon but also provide evidence to
support the notion that hypoxia-induced cell-cycle arrest is
directly related to the shortage of deoxynucleotide precursors
for DNA synthesis (1).
The expression of hypoxia-responsive genes is primarily
regulated by HIF-1a / HIF-1b transcription factor. The HIF
heterodimer binds to a speciﬁc DNA-binding element, the
HRE matrix, which contains a core sequence (50-RCGTG-30)
and uncharacterized ﬂanking sequences in the promoter region
Figure 6. DFO-mediated suppression of CAD mRNA is HIF-1a dependent. Cells were transfected with specific siRNA against HIF-1a (siHIF), scrambled
sequenceofsiRNA(sr-HIF),ortransfectionreagentonly(Mock)asindicated.Transfectedcellswerethentreatedwith10mMDFOorvehicle(Con)for8handlevels
of endogenous HIF-1a protein (A) and CAD mRNA transcripts (B) were determined by western blot and/or real-time RT–PCR. (A) a representative western blot
showsthatHIF-1awasinducedbyDFOtreatmentincellstransfectedwithscrambledsiRNAormocktransfectionbutnotincellstransfectedwithsiHIF-1a.(B)Data
show means and standard errors of three independent experiments performed in duplicate. Asterisks indicate significant difference from vehicle treated group
(P < 0.05).
Figure 7. In vivo binding of HIF-1a on the HRE matrix located at  67/ 54
of the cad promoter. (A) Colo320DM cells were cultured under normoxia (N)
or hypoxia (H) conditions for 16 h as described and subjected to chromatin
immunoprecipitation-PCR amplification (ChIP) assay.Anti-HIF-1a poly-
clonal antibody (HIF-1a) or rabbit IgG (IgG) was used to precipitated
sonicated chromatin. Sonicated cell lysate (2 ml) was used as input control.
(B) Colo320DM and IMR32 cells were treated with DFO (10 mM for
Colo320DM and 1 mM for IMR32, respectively) for indicated time and ChIP
assays were performed. V: DMSO vehicle treated groups, D: DFO-treated
groups. Number indicates time of treatment in hour. The gel pictures are
representative of four independent experiments.
5196 Nucleic Acids Research, 2005, Vol. 33, No. 16or other untranslated regions (30,31). Owing to the shortness
of the sequence, the core HREs were observed frequently
in the target-gene promoter, but only a few of them are
effective for hypoxia-regulated gene expression. Cumulative
data have demonstrated that the core HRE is necessary but
not sufﬁcient to regulate hypoxia-responsive genes (25,32,33).
By using bioinformatic methodology, we identiﬁed one such
HRE matrix in the proximal region of human cad promoter
( 67/ 54) and conﬁrmed that this HRE matrix is important
in HIF-1a-regulated cad-promoter activity by providing
several lines of evidence. First, the promoter activity of the
intact human cad promoter ( 710/+122) was down-regulated
under hypoxic condition or an increase in nuclear HIF-1a
concentrations caused by DFO treatment. Second, the 25
bps human cad HRE matrix-containing plasmid responded
to hypoxic stress exactly as that of intact cad promoter.
Third, effect of hypoxia on cad-promoter activity was
abrogated when the 25 bp HRE was mutated or by forced
overexpression of dominant-negative HIF-1a. Fourth,
physical binding of HIF-1a to the cad promoter was demon-
strated by ChIP assay and the amounts of cad promoter-
bound HIF-1a was signiﬁcantly increased under hypoxic
conditions.
The repression of cad-promoter activity by HIF-1a concurs
with the notion that hypoxia causes a halt of pyrimidine
nucleotide biosynthesis and that HIF-1a is indispensable for
hypoxia-induced cell-cycle arrest (4). However, the in-depth
mechanism responsible for inhibiting HIF-1-mediated cad-
gene expression is not completely elucidated. The proximal
cad promoter contains an E-box essential for c-Myc-induced
CAD expression (34). It has been reported that HIF-1a can
counteract c-Myc’s function independent of HIF-1a’s tran-
scriptional activity and DNA-binding ability (35). In the cur-
rent study, by showing that dominant-negative HIF-1a
blocked the effects of hypoxia, we found that the binding
of HIF-1a to the HRE matrix and retention of transcriptional
capability are necessary for suppression of cad-promoter
activity. Alternatively, it was reported that ATP-dependent
hSWI/SNF chromatin remodeling complex containing
mSin3A/histone deacetylase 2 (HDAC2) co-repressor might
also be involved in the transcriptional repression of the cad
gene (36). It is possible that the binding of HIF-1a to the HRE
matrix recruits histone modiﬁcation complex or other co-
repressors to cad promoter and thus suppresses gene transcrip-
tion. Further investigations on the nature of the partners of
HIF-1 involved in cad down-regulation are crucial to elucidate
the mechanisms involved in the repression of HIF-1-
dependent hypoxia down-regulated genes.
In summary, we have demonstrated for the ﬁrst time that
HIF-1a transcriptionally suppressed cad-gene expression
under hypoxia. This effect was unequivocally observed in
four cancerous and non-cancerous cell lines and one primary
culture cell type, which demonstrated that it is a common
phenomenon. Given the critical role of CAD in nucleotides
biosynthesis and consequent DNA replication, our data pro-
vide a functional link between hypoxia and cell-cycle arrest.
Further investigation is warranted to explore effects of CAD
suppression on the upregulation of checkpoint proteins and
cell-cycle arrest when cells are under hypoxic stress, which
mayprovidevaluableinformationindesigningnovelregimens
for treating hypoxia-related diseases.
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